Metraipolis › archive › dc_293acd80d85c

Real-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With HIV Starting Therapy… — Europe PMC PMID:40152537

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40152537
DOI
10.1093/cid/ciaf162
License (as archived)
solo-consultazione
Archived
2026-11-08T21:21:00.098Z
SHA-256 of the archived text
3365dcb893d9220a7cab8c8d49a285c49f5b9976b28857e35a35e5f3f87074c3
Stable URL of this page
https://metraipolis.com/documento/dc_293acd80d85c

How to cite

Real-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With HIV Starting Therapy… — Europe PMC PMID:40152537 — Europe PMC (en), https://europepmc.org/article/MED/40152537 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_293acd80d85c (Metraipolis archive dc_293acd80d85c, sha256 3365dcb893d9220a7cab8c8d49a285c49f5b9976b28857e35a35e5f3f87074c3)
BibTeX
@misc{dc293acd80d85c,
  title = {Real-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With HIV Starting Therapy… — Europe PMC PMID:40152537},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40152537},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_293acd80d85c; sha256 3365dcb893d9220a7cab8c8d49a285c49f5b9976b28857e35a35e5f3f87074c3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40152537. Agents can read the archived copy with the MCP tool read_document.